Share URL
Embed chart view
StockViz
Adaptive Biotechnologies Corporation
NasdaqGS:ADPT
Sector
Location
Market Cap
USD 1.59 B
Share Price
USD 10.44
Avg Daily Volume
2,234,471
Change (1 day)
0.48%
Change (1 year)
126.96%
Change (YTD)
74.00%
Adaptive Biotechnologies Corporation Share Price Year-To-Date (YTD) return on July 30, 2025: 74.00%
Adaptive Biotechnologies Corporation Share Price Year-To-Date (YTD) return is 74.00% on July 30, 2025. Share price reflects current trading price of a company's stock; influenced by market dynamics and company performance. Year-to-Date (YTD) return is is the percentage change in the price of a stock from the start of the calendar year up to the current date, it shows how much the stock has gained or lost since the beginning of the year.
-
Adaptive Biotechnologies Corporation 52-week low Share Price is USD 12.16 on July 30, 2025, which is 16.48% above the current Share Price.
-
Adaptive Biotechnologies Corporation 52-week low Share Price is USD 4.00 on July 30, 2025, which is -61.69% below the current Share Price.
-
Adaptive Biotechnologies Corporation average Share Price for the last 52 weeks is USD 7.23.
Competitors
Sanofi
USD 97.52
SAN.PA
-1.60
-1.62%
Moderna, Inc.
USD 32.15
MRNA
-0.51
-1.56%
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
USD 8.20
603392.SS
+0.03
0.43%
Swedish Orphan Biovitrum AB (publ)
USD 28.44
SOBI.ST
-2.22
-7.23%
Chongqing Zhifei Biological Products Co., Ltd.
USD 3.45
300122.SZ
+0.01
0.41%
Ionis Pharmaceuticals, Inc.
USD 43.37
IONS
+1.89
4.56%
Rhythm Pharmaceuticals, Inc.
USD 84.66
RYTM
-0.97
-1.13%
Shanghai Junshi Biosciences Co., Ltd.
USD 3.37
1877.HK
-0.02
-0.55%
Vaxcyte, Inc.
USD 34.82
PCVX
+0.14
0.40%
Hualan Biological Engineering Inc.
USD 2.33
002007.SZ
-0.01
-0.31%
Bavarian Nordic A/S
USD 35.99
BAVA.CO
-0.58
-1.58%
NewAmsterdam Pharma Company N.V.
USD 22.43
NAMS
-0.35
-1.54%
Ligand Pharmaceuticals Incorporated
USD 135.23
LGND
+3.65
2.77%
Apellis Pharmaceuticals, Inc.
USD 19.00
APLS
+0.05
0.26%
Apogee Therapeutics, Inc.
USD 37.61
APGE
-0.32
-0.84%
Key Data
| Date | Share Price Year-To-Date (YTD) return | Price to Earnings Ratio (P/E) | Price to Book Ratio (P/B) | Price to Sales Ratio (P/S) |
|---|
Competitors
Sanofi
USD 97.52
SAN.PA
-1.60
-1.62%
Moderna, Inc.
USD 32.15
MRNA
-0.51
-1.56%
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
USD 8.20
603392.SS
+0.03
0.43%
Swedish Orphan Biovitrum AB (publ)
USD 28.44
SOBI.ST
-2.22
-7.23%
Chongqing Zhifei Biological Products Co., Ltd.
USD 3.45
300122.SZ
+0.01
0.41%
Ionis Pharmaceuticals, Inc.
USD 43.37
IONS
+1.89
4.56%
Rhythm Pharmaceuticals, Inc.
USD 84.66
RYTM
-0.97
-1.13%
Shanghai Junshi Biosciences Co., Ltd.
USD 3.37
1877.HK
-0.02
-0.55%
Vaxcyte, Inc.
USD 34.82
PCVX
+0.14
0.40%
Hualan Biological Engineering Inc.
USD 2.33
002007.SZ
-0.01
-0.31%
Bavarian Nordic A/S
USD 35.99
BAVA.CO
-0.58
-1.58%
NewAmsterdam Pharma Company N.V.
USD 22.43
NAMS
-0.35
-1.54%
Ligand Pharmaceuticals Incorporated
USD 135.23
LGND
+3.65
2.77%
Apellis Pharmaceuticals, Inc.
USD 19.00
APLS
+0.05
0.26%
Apogee Therapeutics, Inc.
USD 37.61
APGE
-0.32
-0.84%